Welcome to our dedicated page for Hamilton Insurance Group, Ltd. SEC filings (Ticker: HG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Hamilton Insurance Group, Ltd.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Hamilton Insurance Group, Ltd.'s regulatory disclosures and financial reporting.
Hamilton Insurance Group, Ltd. (HG) filed a Form 144 notifying an intended sale of 18,988 common shares held by an insider through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $455,713.90 and approximately 65,606,760 shares outstanding. The securities offered for sale were primarily shares delivered upon restricted stock vesting and performance stock units between 11/10/2024 and 03/01/2025, totaling specific lots of 2,088; 1,569; 2,060; 5,815; and 7,456 shares. The filer certifies no undisclosed material adverse information and notes no sales in the past three months.
Alexander James Baker, Chief Risk Officer of Hamilton Insurance Group, Ltd. (HG), reported the sale of 6,000 Class B common shares on 08/13/2025 at a weighted average price of $23.7873 per share under a transaction coded "S". After the sale the reporting person beneficially owned 116,338 Class B shares in a direct capacity. The filer indicated the sale was made pursuant to a Rule 10b5-1 plan and disclosed that the reported price is a weighted average from multiple trades between $23.75 and $23.81.
Megan Jane Graves, listed as an officer (CEO, Hamilton Re) and director of Hamilton Insurance Group, Ltd. (HG), reported a sale of Class B common shares. The filing shows a total disposition of 50,000 Class B shares executed on 08/13/2025 at a weighted-average price of $23.7468 per share. After this transaction, the reporting person beneficially owned 104,674 Class B shares, held directly. The form includes a footnote stating the sale occurred in multiple transactions at prices ranging from $23.50 to $24.04 and offers to provide a breakdown of quantities by price on request.
Hamilton Insurance Group, Ltd. (HG) reporting person Megan Jane Graves, CEO of Hamilton Re, sold 50,000 Class B common shares on 08/12/2025 at a weighted average price of $23.2739 per share. After the sale the reporting person beneficially owned 154,674 Class B common shares. The filing notes the sale occurred in multiple transactions at prices ranging from $23.02 to $23.53 and that detailed allocation by price is available on request. The Form 4 was signed by an attorney-in-fact on 08/14/2025.
This Form 144 notice reports a proposed Rule 144 sale of 6,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $139,860 and an approximate sale date of 08/13/2025. The shares are part of an outstanding share base of 65,606,760 shares and were acquired as Restricted Stock Units on 01/01/2023. The filing shows no sales in the past three months for the reporting person and includes the broker's address. Several standard filer and issuer identification fields (such as filer CIK and issuer name/contact details) are not populated in the provided content.
Hamilton Insurance Group, Ltd. notice reports a proposed sale of 100,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $2,331,000 and an approximate sale date of 08/12/2025. The issuer has 65,606,760 shares outstanding. The 100,000 shares were acquired as restricted stock vesting under a registered plan on multiple dates in 2024–2025, with the individual vesting lots listed in the notice and totaling 100,000 shares. Separately, Megan Jane Graves sold 25,000 shares on 05/16/2025 for gross proceeds of $525,500. The filer represents there is no undisclosed material adverse information.